Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study (Q36618943)

15 August 2017

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study (English)

1 reference

15 August 2017

6

Hallmans G

1 reference

15 August 2017

1

Lenner P

1 reference

15 August 2017

Wiklund F

2

1 reference

15 August 2017

Emdin SO

3

1 reference

15 August 2017

Arnerlöv C

4

1 reference

15 August 2017

Eklund C

5

1 reference

15 August 2017

Zentgraf H

7

1 reference

15 August 2017

Dillner J

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

5-6

1 reference

15 August 2017

927-932

1 reference

Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

The relationship between serum p53 autoantibodies and characteristics of human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Absence of p53 autoantibodies in a significant proportion of breast cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Genetic basis for p53 overexpression in human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Analysis of the anti-p53 antibody response in cancer patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Antibodies against p53 are associated with poor prognosis of colorectal cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362685

p53 mutations in human cancers

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690148

p53: oncogene or anti-oncogene?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690148

p53 antibodies in patients with various types of cancer: assay, identification, and characterization

21 January 2018

1 reference

12 December 2020

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

12 December 2020

Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival

1 reference

12 December 2020

Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?

1 reference

12 December 2020

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

12 December 2020

Maintenance of p53 alterations throughout breast cancer progression

1 reference

12 December 2020

Mutations in the p53 gene in primary human breast cancers

1 reference

12 December 2020

Serum p53 auto-antibodies: incidence in familial breast cancer

1 reference

12 December 2020

The significance of p53 autoantibodies in the serum of patients with breast cancer

1 reference

12 December 2020

Detection of p53 auto-antibodies in the sera of breast cancer patients with a new recurrence using an ELISA assay. Does a correlation with the recurrence free interval exist?

1 reference

12 December 2020

Characterisation and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690148

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

10070892

1 reference